vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Paysign, Inc. (PAYS). Click either name above to swap in a different company.

Paysign, Inc. is the larger business by last-quarter revenue ($22.8M vs $19.2M, roughly 1.2× CuriosityStream Inc.). Paysign, Inc. runs the higher net margin — 6.0% vs -19.7%, a 25.7% gap on every dollar of revenue. On growth, Paysign, Inc. posted the faster year-over-year revenue change (45.8% vs 35.8%). Paysign, Inc. produced more free cash flow last quarter ($47.5M vs $3.9M). Over the past eight quarters, Paysign, Inc.'s revenue compounded faster (31.3% CAGR vs 26.5%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Paysign, Inc. is a specialized payment solutions provider that designs and delivers customized prepaid card programs, end-to-end payment processing services, and digital disbursement tools. Its core served segments include healthcare, corporate incentives, and general consumer markets, with primary operations and client bases across North America.

CURI vs PAYS — Head-to-Head

Bigger by revenue
PAYS
PAYS
1.2× larger
PAYS
$22.8M
$19.2M
CURI
Growing faster (revenue YoY)
PAYS
PAYS
+10.0% gap
PAYS
45.8%
35.8%
CURI
Higher net margin
PAYS
PAYS
25.7% more per $
PAYS
6.0%
-19.7%
CURI
More free cash flow
PAYS
PAYS
$43.6M more FCF
PAYS
$47.5M
$3.9M
CURI
Faster 2-yr revenue CAGR
PAYS
PAYS
Annualised
PAYS
31.3%
26.5%
CURI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CURI
CURI
PAYS
PAYS
Revenue
$19.2M
$22.8M
Net Profit
$-3.8M
$1.4M
Gross Margin
57.7%
Operating Margin
-17.6%
8.1%
Net Margin
-19.7%
6.0%
Revenue YoY
35.8%
45.8%
Net Profit YoY
-34.6%
-0.7%
EPS (diluted)
$-0.07
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
PAYS
PAYS
Q4 25
$19.2M
$22.8M
Q3 25
$18.4M
$21.6M
Q2 25
$19.0M
$19.1M
Q1 25
$15.1M
$18.6M
Q4 24
$14.1M
$15.6M
Q3 24
$12.6M
$15.3M
Q2 24
$12.4M
$14.3M
Q1 24
$12.0M
$13.2M
Net Profit
CURI
CURI
PAYS
PAYS
Q4 25
$-3.8M
$1.4M
Q3 25
$-3.7M
$2.2M
Q2 25
$784.0K
$1.4M
Q1 25
$319.0K
$2.6M
Q4 24
$-2.8M
$1.4M
Q3 24
$-3.1M
$1.4M
Q2 24
$-2.0M
$697.1K
Q1 24
$-5.0M
$309.1K
Gross Margin
CURI
CURI
PAYS
PAYS
Q4 25
57.7%
Q3 25
56.3%
Q2 25
61.6%
Q1 25
62.9%
Q4 24
58.9%
Q3 24
55.5%
Q2 24
52.9%
Q1 24
52.6%
Operating Margin
CURI
CURI
PAYS
PAYS
Q4 25
-17.6%
8.1%
Q3 25
-24.5%
7.3%
Q2 25
2.5%
7.5%
Q1 25
0.5%
13.4%
Q4 24
-27.4%
3.0%
Q3 24
-25.8%
4.5%
Q2 24
-20.6%
0.9%
Q1 24
-30.4%
-2.0%
Net Margin
CURI
CURI
PAYS
PAYS
Q4 25
-19.7%
6.0%
Q3 25
-20.4%
10.3%
Q2 25
4.1%
7.3%
Q1 25
2.1%
13.9%
Q4 24
-19.9%
8.8%
Q3 24
-24.3%
9.4%
Q2 24
-16.4%
4.9%
Q1 24
-42.0%
2.3%
EPS (diluted)
CURI
CURI
PAYS
PAYS
Q4 25
$-0.07
$0.02
Q3 25
$-0.06
$0.04
Q2 25
$0.01
$0.02
Q1 25
$0.01
$0.05
Q4 24
$-0.05
$0.02
Q3 24
$-0.06
$0.03
Q2 24
$-0.04
$0.01
Q1 24
$-0.09
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
PAYS
PAYS
Cash + ST InvestmentsLiquidity on hand
$27.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$48.5M
Total Assets
$75.7M
$276.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
PAYS
PAYS
Q4 25
$27.3M
Q3 25
$27.8M
Q2 25
$28.1M
Q1 25
$33.4M
Q4 24
$32.1M
Q3 24
$33.2M
Q2 24
$39.5M
Q1 24
$38.8M
Stockholders' Equity
CURI
CURI
PAYS
PAYS
Q4 25
$41.5M
$48.5M
Q3 25
$47.2M
$45.8M
Q2 25
$49.8M
$42.2M
Q1 25
$58.1M
$39.3M
Q4 24
$57.8M
$30.4M
Q3 24
$62.2M
$28.5M
Q2 24
$64.8M
$26.9M
Q1 24
$67.0M
$25.5M
Total Assets
CURI
CURI
PAYS
PAYS
Q4 25
$75.7M
$276.3M
Q3 25
$74.7M
$209.5M
Q2 25
$78.7M
$193.9M
Q1 25
$85.3M
$205.1M
Q4 24
$86.2M
$179.0M
Q3 24
$87.6M
$167.0M
Q2 24
$90.9M
$182.3M
Q1 24
$94.6M
$173.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
PAYS
PAYS
Operating Cash FlowLast quarter
$4.0M
$48.1M
Free Cash FlowOCF − Capex
$3.9M
$47.5M
FCF MarginFCF / Revenue
20.5%
208.7%
Capex IntensityCapex / Revenue
0.1%
2.6%
Cash ConversionOCF / Net Profit
35.29×
TTM Free Cash FlowTrailing 4 quarters
$51.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
PAYS
PAYS
Q4 25
$4.0M
$48.1M
Q3 25
$4.4M
$6.8M
Q2 25
$2.8M
$3.6M
Q1 25
$1.9M
$-6.0M
Q4 24
$3.0M
$14.3M
Q3 24
$2.3M
$-20.2M
Q2 24
$2.2M
$20.6M
Q1 24
$666.0K
$8.2M
Free Cash Flow
CURI
CURI
PAYS
PAYS
Q4 25
$3.9M
$47.5M
Q3 25
$6.3M
Q2 25
$3.6M
Q1 25
$1.8M
$-6.1M
Q4 24
$14.2M
Q3 24
$-20.3M
Q2 24
$20.4M
Q1 24
$8.2M
FCF Margin
CURI
CURI
PAYS
PAYS
Q4 25
20.5%
208.7%
Q3 25
29.2%
Q2 25
18.6%
Q1 25
12.2%
-32.9%
Q4 24
91.0%
Q3 24
-133.0%
Q2 24
142.4%
Q1 24
62.1%
Capex Intensity
CURI
CURI
PAYS
PAYS
Q4 25
0.1%
2.6%
Q3 25
0.0%
2.1%
Q2 25
0.0%
0.5%
Q1 25
0.5%
0.4%
Q4 24
0.0%
0.7%
Q3 24
0.0%
0.8%
Q2 24
0.0%
1.0%
Q1 24
0.0%
0.4%
Cash Conversion
CURI
CURI
PAYS
PAYS
Q4 25
35.29×
Q3 25
3.05×
Q2 25
3.56×
2.62×
Q1 25
6.03×
-2.33×
Q4 24
10.43×
Q3 24
-14.03×
Q2 24
29.48×
Q1 24
26.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURI
CURI

Segment breakdown not available.

PAYS
PAYS

Plasma Industry$12.6M55%
Pharma Industry$9.6M42%
Other$558.4K2%

Related Comparisons